Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5711659

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Functional
Cytotoxicity against mouse Ba/F3 EGFR-Del19 cells assessed as inhibition of cell viability incubated for 72 hrs by CellTiter-Glo assay
11
Total Activities
11
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Functional
Organism Mus musculus
Cell Type Ba/F3 EGFR-Del19
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.
Uchibori K, Inase N, Araki M, Kamada M, Sato S, Okuno Y, Fujita N, Katayama R.
Nat Commun (2017) 8 : 14768 -14768
PubMed 28287083 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 11 7.35 8.77

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL3353410 OSIMERTINIB 4.0 1 8.77
CHEMBL3787344 NAZARTINIB 2.0 1 8.54
CHEMBL939 GEFITINIB 4.0 1 8.23
CHEMBL3397300 1 7.43
CHEMBL3545311 BRIGATINIB 4.0 1 7.41
CHEMBL4203266 1 7.05
CHEMBL1171837 PONATINIB 4.0 1 6.90
CHEMBL509032 TAE-684 1 6.50
CHEMBL3545360 ASP-3026 1.0 1 6.35
CHEMBL2403108 CERITINIB 4.0 1 6.28
CHEMBL1173655 AFATINIB 4.0 1 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL3353410 OSIMERTINIB IC50 = 1.7 nM 8.77
CHEMBL3787344 NAZARTINIB IC50 = 2.9 nM 8.54
CHEMBL939 GEFITINIB IC50 = 5.9 nM 8.23
CHEMBL3397300 IC50 = 36.9 nM 7.43
CHEMBL3545311 BRIGATINIB IC50 = 39.4 nM 7.41
CHEMBL4203266 IC50 = 90.0 nM 7.05
CHEMBL1171837 PONATINIB IC50 = 126.5 nM 6.90
CHEMBL509032 TAE-684 IC50 = 314.4 nM 6.50
CHEMBL3545360 ASP-3026 IC50 = 450.1 nM 6.35
CHEMBL2403108 CERITINIB IC50 = 524.3 nM 6.28
CHEMBL1173655 AFATINIB IC50 < 0.3 nM -